Tomas Kelly

PFD Report All Responded Ref: 2017-0412
Date of Report 22 November 2017
Coroner Heidi Connor
Coroner Area Nottinghamshire
Response Deadline ✓ from report 17 January 2018
All 1 response received · Deadline: 17 Jan 2018
Response Status
Responses 1 of 3
56-Day Deadline 17 Jan 2018
All responses received
About PFD responses

Organisations named in PFD reports must respond within 56 days explaining what actions they are taking.

Source: Courts and Tribunals Judiciary

Coroner’s Concerns
My concerns are :

1. Talking to parents
a. I did not have concerns about the medical professionals being aware of the increased risks associated with infection in children with Downs Syndrome. I heard no evidence of the parents being made aware of this however – either when he was discharged from hospital on 22 October 2016 or when he was seen by his GP on 21 November 2016.
b. Tomas’ parents said they may have sought additional medical assistance if they had known about these risks.
c. Whilst this may be happening to some extent in community paediatrics, it is important for health professionals in acute settings (including primary care) to be advised to share these risks with parents/ carers, so that they can adopt an appropriate threshold for seeking medical assistance.
2. Vaccination against chicken pox
a. The evidence confirmed that it is not the chicken pox per se which creates a risk. Rather it is the immunosuppressant effect of this – creating a risk of more serious infections as a result.
b. We heard from a community paediatrician that, as matters stand, there is no plan to vaccinate all children against chicken pox. This is limited to certain high risk groups only.
c. It is clear that children with Downs Syndrome are at increased risk – both of contracting infection and of the infections being more serious.
d. Careful consideration should be given to including children with Downs Syndrome to the category of children who will be routinely offered this vaccination.

The fact that a Regulation 28 report has been issued should not be interpreted as a criticism of the recipient organisation. This point has been made clearly in the case of R (Dr Siddiqui and Dr Paeprer-Rochricht) v Assistant Coroner for East London (Admin Court CO/2892/2017 decision 28 Sept. 2017)
Responses
Joint Committee on Vacccination and Immunisation
2 Dec 2017
Response received
View full response
Dear Mrs Connor,

Re: Tomas Kelly

I am writing in my capacity as Chair of the Joint Committee on Vaccination and Immunisation (JCVI), which advises the Department of Health (DH) on immunisation, in response to your Regulation 28 Report, To Prevent Future Deaths. This was clearly a very distressing case and I am in full agreement with you that all efforts should be made to minimise such events.

I understand from your report that the cause of death for Tomas Kelly was confluent bronchopneumonia. The coroner’s concerns laid out in that report came under two headings 1 “talking to parents” and 2 “vaccination against chickenpox” with the below points under 2.

a. “The evidence confirmed that it is not the chicken pox per se which creates a risk. Rather it is the immunosuppressant effect of this – creating a risk of more serious infections as a result.
b. We heard from a community paediatrician that, as matters stand, there is no plan to vaccinate all children against chicken pox. This is limited to certain high risk groups only.
c. It is clear that children with Downs Syndrome are at increased risk – both of contracting infection and of the infections being more serious.
d. Careful consideration should be given to including children with Downs Syndrome to the category of children who will be routinely offered this vaccination.”

Varicella immunisation is not offered to all children in the UK as part of the routine immunisation programme, but is offered to individuals in specific groups because of their 1

increased risk of serious disease should they contract varicella. Down’s syndrome is not currently included in the list of high risk groups, as an increased (complicated) varicella risk has not previously been identified. Your communication is timely as JCVI is currently undertaking a review of its advice on varicella vaccination and will give consideration to your suggestion regarding Down’s syndrome during one of the 3 meetings in 2018.
Report Sections
Investigation and Inquest
On 26 July 2017 I commenced an investigation into the death of Tomas Kelly, aged 3. The investigation concluded at the end of the inquest on 14 November 2017. The conclusion of the inquest was natural causes.
Circumstances of the Death
October hospital admission

Tomas was diagnosed with an upper respiratory tract infection by a GP on 17 October 2016. He was prescribed antibiotics (Amoxicillin) in liquid form. Tomas did not like the taste of this and it was difficult to persuade him to take this. He suffered a choking episode on 18 October, and required resuscitation by his parents. He was admitted to hospital that day. He was diagnosed with aspiration pneumonia and a chest infection.

Tomas was kept in hospital until 22 October and was given what were described as ‘strong antibiotics’. One of the reasons for this was that he had Down’s Syndrome. He was therefore known to be at greater risk – both of developing infections and for those infections to be potentially more dangerous than they might be for children without this condition.

Events post hospital admission

Tomas appeared to recover after the October hospital admission, but soon afterwards contracted chicken pox. His parents became concerned about him on the night of 20 November. They said his breathing was very rapid. His lips turned blue and he had raised temperatures, which they were treating with paracetamol (in the form of Calpol).

Tomas was seen by a GP, , on 21 November 2016, in an emergency appointment. did not consider him to be a particularly unwell child. He examined and listened to Tomas’ airways from the back. He did not examine or listen to his chest from the front. He said that he prescribed antibiotics (this time Flucloxacillin) because of the risk that Tomas might develop infection in view of his chicken pox. He said he saw no signs of infection when he examined Tomas. He recorded a normal respiration rate, pulse and capillary refill time. He did not record a temperature – he felt Tomas’ forehead with his hand. He did not measure oxygen saturations. He said he did not need to.

did not refer Tomas to paediatricians. Paediatric witnesses gave evidence that, if they had been contacted, in view of the risk factors for Tomas, they would have asked for him to come to hospital later that day. He would in those circumstances have been observed for a number of hours. He may have been admitted and had intravenous antibiotics administered. It is not clear whether earlier referral would have changed the outcome.

The relevant risk factors for Tomas by 21 November included :

 His Down’s Syndrome  Recent chicken pox  Recent admission to hospital following likely arrest  Recent diagnosis of aspiration pneumonia and chest infection (during his hospital admission 18 -22 October 2016).

Tomas’ condition deteriorated very rapidly at home in the early hours of 22 November 2016. He died in hospital that morning.

The cause of death following a PM was confluent bronchopneumonia. The evidence of the paediatric pathologist was that patients with Downs Syndrome are more prone to severe lung infections. She told us that children with Downs show a 12-times increased risk of mortality due to infection.

The parents gave difficult and poignant evidence at the inquest. They said they wished they had known about the increased risks for Tomas. If they had known that infections can be more risky for children with Downs Syndrome, they may have reacted differently or sought further medical assistance sooner. They think that other parents with children who have Downs Syndrome should be made aware of these risks in future.
Related Inquiry Recommendations

Public inquiry recommendations addressing similar themes

Pre-1996 Transfusion Testing
Infected Blood Inquiry
Delayed patient infection risk notification
Eligibility Conditions for Infected Persons
Infected Blood Inquiry
Delayed patient infection risk notification
Monitor Brook House contract performance robustly
Brook House Inquiry
Poor prevention and early intervention
Review and reduce cell lock-in periods
Brook House Inquiry
Poor prevention and early intervention
HCV Testing for Pre-1991 Transfusion Recipients
Penrose Inquiry
Delayed patient infection risk notification
CDI senior assessment and treatment
Vale of Leven Inquiry
Delayed patient infection risk notification
Laboratory specimen processing
Vale of Leven Inquiry
Delayed patient infection risk notification
Effective CDI patient isolation
Vale of Leven Inquiry
Delayed patient infection risk notification
Isolation for infectious diarrhoea
Vale of Leven Inquiry
Delayed patient infection risk notification

Data sourced from Courts and Tribunals Judiciary under the Open Government Licence.